3 Results for "

disease-modifying effects

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "disease-modifying effects" in MCE Product Catalog:

Cat. No.: HY-11044
CAS No.: 1039399-17-1
Purity:  99.1%
PF-03654746 Tosylate is a potent, selective and brain-penetrant histamine H3 receptor antagonist. PF-03654746 Tosylate reduces allergen-induced nasal symptoms . PF-03654746 Tosylate has potential for treatment of human cognitive disorders, improves cognitive efficacy and disease-modifying effects in Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-11045
CAS No.: 935840-31-6
PF-03654746 is a potent and selective histamine H3 receptor antagonist with high brain penetration. PF-03654746 reduces allergen-induced nasal symptoms, might be a novel therapeutic strategy to further explore allergic rhinitis . PF-03654746 improves cognitive efficacy and disease-modifying effects in Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-156102
CAS No.: 3056613-20-5
Target:  

Bcr-Abl

Research Areas:  

Neurological Disease

c-ABL-IN-5 is a selective c-Abl inhibitor with neuroprotective effects. c-ABL-IN-5 has blood-brain barrier penetrability, metabolic stability and good pharmacokinetic properties. When c-ABL-IN-5 is labeled with [18F] (compound [18F]3), it can be used as a tracer to evaluate disease-modifying efficacy by complementary positron emission tomography (PET). c-ABL-IN-5 can be used in the study of neurodegenerative diseases such as Parkinson's disease (PD) .
loading...
    loading...